Zobrazeno 1 - 10
of 40
pro vyhledávání: '"MYC Positive"'
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 62-70 (2022)
Angiosarcoma of the breast is an unusual malignancy and carries a poor prognosis, with a 5-year overall survival rate ranging from 27 to 48%. Radiotherapy-induced angiosarcoma (RIAS) of the breast is very uncommon, with an estimated incidence of 1 in
Externí odkaz:
https://doaj.org/article/424e6db7c15245fc8d100d3af403134e
ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma
Publikováno v:
OncoTargets and therapy
Jianjun Wang,1,* Yuchen Li,2,* Binbin Xu,3,* Jiao Dong,1 Haiyan Zhao,1 Dongxia Zhao,1 Yong Wu4 1Department of Pediatric Medicine, Gansu Provincial People’s Hospital, Lanzhou City 730000, Gansu Province, People’s Republic of China; 2Fudan Universi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d43410751a26f7f036f8c0de28c41b
http://europepmc.org/articles/PMC7802773
http://europepmc.org/articles/PMC7802773
Autor:
Duncan Stearns, Hiroaki Miyahara, Manabu Natsumeda, Ulf Dietrich Kahlert, Fausto J. Rodriguez, Satoshi Nakata, Nicolas Skuli, Allison Hanaford, Yang Liu, Charles G. Eberhart, Eric H. Raabe, Sama Ahsan
Publikováno v:
Neuropathology
MYC amplification is common in Group 3 medulloblastoma and is associated with poor survival. Group 3 and Group 4 medulloblastomas are also known to have elevated levels of histone H3-lysine 27-tri-methylation (H3K27me3), at least in part due to high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac0bc2052f60a78ce1b6020b2a46dcb
https://doi.org/10.1111/neup.12534
https://doi.org/10.1111/neup.12534
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Lung adenocarcinoma (LUAD) is the main histological type of lung cancer, which is the leading cause of cancer-related deaths. Long non-coding RNAs (lncRNAs) were recently revealed to be involved in various cancers. However, the clinical relevance and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a69dfe14b6c070a856bf333942dec5
https://doi.org/10.3389/fcell.2021.631259
https://doi.org/10.3389/fcell.2021.631259
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aleksandra Kotyl, Renata Woroniecka, Klaudia Borkowska, Beata Grygalewicz, Jolanta Rygier, Katarzyna Blachnio, Grzegorz Rymkiewicz, Zbigniew Bystydzienski, Barbara Pienkowska-Grela, Beata Nowakowska
Publikováno v:
American Journal of Clinical Pathology
Objectives The latest revision of lymphoma’s World Health Organization classification describes the new provisional entity “Burkitt-like lymphoma with 11q aberration” (BLL, 11q) as lacking MYC rearrangement, but harboring the specific11q-gain/l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec371b5199bc58bb7cee3da341689360
https://doi.org/10.1093/ajcp/aqx139
https://doi.org/10.1093/ajcp/aqx139
Publikováno v:
Leukemia & Lymphoma. 59:1807-1813
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. Within ALL, precursor B-cell disease predominates and now has survival >90%. Mature B-cell, or Burkitt leukemia/lymphoma, is distinct from ALL and requires short intensive chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348dd57b28036b178f0c86c8fb6e9532
https://doi.org/10.1080/10428194.2017.1387914
https://doi.org/10.1080/10428194.2017.1387914
Publikováno v:
Journal of Cutaneous Pathology. 44:925-930
Background Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a malignant primary cutaneous T-cell lymphoma that shares significant clinical, histopathologic and immunophenotypic overlap with lupus erythematosus panniculitis (LEP). Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::990996c71395ff4de87b2c871c13d527
https://doi.org/10.1111/cup.13025
https://doi.org/10.1111/cup.13025
Autor:
Rami S. Komrokji, Najla Al Ali, Eric Padron, Ling Zhang, Andrew T. Kuykendall, Pukhraz Basra, Chetasi Talati, Nicole D. Vincelette, Kendra Sweet, Seongseok Yun, Jeffrey E. Lancet, David Gajzer, David A. Sallman
Publikováno v:
Blood. 136:39-40
Acute myeloid leukemia (AML) with myelodysplasia-related changes (AML-MRC) is shown to be associated with dismal clinical outcomes and there remains a pressing need for new therapeutic strategies to improve survival outcomes. It is also important to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c603cf76f7494f18a9eb68cc013cc2ec
https://doi.org/10.1182/blood-2020-137116
https://doi.org/10.1182/blood-2020-137116
Publikováno v:
Journal of biochemistry. 167(4)
Acute myeloid leukaemia (AML) is a frequently diagnosed malignancy in adults. Long non-coding RNA (lncRNA) colon cancer-associated transcript 1 (CCAT1) has been well known to play vital roles in multiple malignancies including AML. Unfortunately, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2bc973ccd92c9ac6e9f3834432ec3aa
https://pubmed.ncbi.nlm.nih.gov/31790145
https://pubmed.ncbi.nlm.nih.gov/31790145